Full Product Name
Anti-MyD88 (CT) Antibody
Product Synonym Names
Anti-MyD88 (CT); MyD88 (CT)
Product Gene Name
anti-MYD88 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Chromosome Location
Chromosome: 3; NC_000003.11 (38179969..38184513). Location: 3p22
3D Structure
ModBase 3D Structure for Q99836
Specificity
Anti-MyD88 (CT) [Rabbit antibody to peptide corresponding to aa 279-296 of human MyD88.]
This antibody recognizes human and mouse MyD88 (35 kD).
Form/Format
100 ug IgG in PBS, pH 7.4, purified by immunoaffinity chromatography.
Antigen
Peptide corresponding to aa 279-296 of human MyD88. The sequence is identical to that of mouse MyD88.
Preservatives
0.02% sodium azide.
Dilutions Instructions
Dilute in PBS or medium which is identical to that used in the assay system.
Preparation and Storage
This antibody is stable for at least one (1) year at -20 degree C. Avoid multiple freeze-thaw cycles.
Other Notes
Small volumes of anti-MYD88 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-MYD88 antibody
Cellular responses induced by the proinflammatory cytokine IL-1 require IL-1 receptor complex (IL-1R1 and IL- 1RacP). Recently, MyD88 was identified as an adapter molecule in the IL-1 signaling pathway. MyD88 associates with and recruits IRAK to the IL-1 receptor. Dominant negative mutants of MyD88 attenuate IL-1Rmediated NF- kappa B activation. MyD88 also functions as a regulator molecule for IL- 18 receptor and human Toll receptor, members of the Toll/IL-1R family of receptors. Targeted disruption of the MyD88 gene results in loss of cellular responses to IL-1 and IL-18, and MyD88-deficient mice lack responses to LPS which require Toll-like receptors 2 and 4 (TLR2 and TLR4) as the signaling receptors. MyD88 is a general adapter protein for the Toll/IL-1R family of receptors and plays an important role in the inflammatory responses induced by cytokines IL-1, IL-18, and LPS. MyD88 is expressed in a variety of tissues.
Product Categories/Family for anti-MYD88 antibody
Neuroscience and Signal Transduction Antibodies
Applications Tested/Suitable for anti-MYD88 antibody
Immunoblot
Application Notes for anti-MYD88 antibody
Immunoblotting: use at 1:500-1:1,000 dilution.
Positive control: Whole cell lysate from Jurkat cells.
NCBI/Uniprot data below describe general gene information for MYD88. It may not necessarily be applicable to this product.
NCBI Accession #
AAC50954.1
[Other Products]
UniProt Primary Accession #
Q99836
[Other Products]
UniProt Secondary Accession #
P78397; Q53XS7; B4DKH8[Other Products]
UniProt Related Accession #
Q99836[Other Products]
Molecular Weight
33,233 Da[Similar Products]
NCBI Official Full Name
MyD88
NCBI Official Synonym Full Names
myeloid differentiation primary response gene (88)
NCBI Official Symbol
MYD88??[Similar Products]
NCBI Official Synonym Symbols
MYD88D
??[Similar Products]
NCBI Protein Information
myeloid differentiation primary response protein MyD88; OTTHUMP00000161718; OTTHUMP00000208595; OTTHUMP00000209058; OTTHUMP00000209059; OTTHUMP00000209060
UniProt Protein Name
Myeloid differentiation primary response protein MyD88
Protein Family
Myeloid differentiation primary response protein
UniProt Gene Name
MYD88??[Similar Products]
UniProt Entry Name
MYD88_HUMAN
NCBI Summary for MYD88
This gene encodes a cytosolic adapter protein that plays a central role in the innate and adaptive immune response. This protein functions as an essential signal transducer in the interleukin-1 and Toll-like receptor signaling pathways. These pathways regulate that activation of numerous proinflammatory genes. The encoded protein consists of an N-terminal death domain and a C-terminal Toll-interleukin1 receptor domain. Patients with defects in this gene have an increased susceptibility to pyogenic bacterial infections. Alternate splicing results in multiple transcript variants. [provided by RefSeq]
UniProt Comments for MYD88
MYD88: Adapter protein involved in the Toll-like receptor and IL-1 receptor signaling pathway in the innate immune response. Acts via IRAK1, IRAK2, IRF7 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Increases IL-8 transcription. Involved in IL-18-mediated signaling pathway. Activates IRF1 resulting in its rapid migration into the nucleus to mediate an efficient induction of IFN-beta, NOS2/INOS, and IL12A genes. Homodimer. Also forms heterodimers with TIRAP. Binds to TLR2, TLR4, IRAK1, IRAK2 and IRAK4 via their respective TIR domains. Interacts with IL18R1. Interacts with BMX, IL1RL1 and IRF7. Interacts with LRRFIP1 and LRRFIP2; this interaction positively regulates Toll-like receptor (TLR) signaling in response to agonist. Interacts with FLII. LRRFIP1 and LRRFIP2 compete with FLII for MYD88-binding. Interacts with IRF1. Ubiquitous. 4 isoforms of the human protein are produced by alternative splicing.
Protein type: Adaptor/scaffold
Chromosomal Location of Human Ortholog: 3p22
Cellular Component: plasma membrane; endosome membrane; cytosol
Molecular Function: identical protein binding; protein binding; death receptor binding
Biological Process: positive regulation of interleukin-17 production; positive regulation of I-kappaB kinase/NF-kappaB cascade; nerve growth factor receptor signaling pathway; positive regulation of interleukin-23 production; positive regulation of interleukin-6 production; signal transduction; toll-like receptor 2 signaling pathway; toll-like receptor 10 signaling pathway; MyD88-dependent toll-like receptor signaling pathway; toll-like receptor 5 signaling pathway; defense response to Gram-positive bacterium; cell surface receptor linked signal transduction; regulation of inflammatory response; toll-like receptor signaling pathway; positive regulation of interferon type I production; innate immune response; toll-like receptor 9 signaling pathway; inflammatory response; toll-like receptor 4 signaling pathway; negative regulation of apoptosis
Disease: Macroglobulinemia, Waldenstrom, Susceptibility To, 1; Myd88 Deficiency
Research Articles on MYD88
1. A composite MyD88/CD40 switch synergistically activates dendritic cells for enhanced antitumor efficacy.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.